Observational studyCNS drugs2021

Real-World Outcomes and Costs Following 6 Months of Treatment with the Long-Acting Injectable (LAI) Aripiprazole Lauroxil for the Treatment of Schizophrenia.

John Lauriello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.